The program began with a welcome from Greek Ambassador to the United States, Alexandra Papadopoulou. This was followed by
The program began with a welcome from Greek Ambassador to the United States, Alexandra Papadopoulou. This was followed by an introduction from Andreas Stavropoulos, Partner at Threshhold Venture Capital, who invests in consumer and enterprise infrastructure, mobility, and technology-enabled services.
The panel was comprised of Greek health technology entrepreneurs at all stages, from early startup through global scale-up, located around the world.
- Dr. Maria Chatzou Dunford, Lifebit (London)
- Eirini Schlosser, Dyania Health (Los Angeles)
- Dr. Maya Thanou, Apeikon Therapeutics (London)
- Eleftheria Zourou, Doctor Anytime (Athens)
The panel was moderated by Margo Georgiadis, Endurance Partner in Residence at General Catalyst. She formerly served as the President and CEO of Ancestry, transforming it into the global leader in family history and consumer genomics with over $1B in subscription revenue. She was also Google President of Americas and Vice President of Global Operations, and before that was the CEO of Mattel.
| Alexandra Papadopoulou
Greek Ambassador to the United States
Ambassador Alexandra PAPADOPOULOU is the first female Ambassador of Greece to the US. Prior to that, she was also the First Female Permanent Representative of Greece to the European Union and served in other important positions, such as Head of the Diplomatic Cabinet of the Prime Minister, Director General for European Affairs/in charge of the Greek Presidency of the EU in 2014, Head of the Greek Liaison Office in Skopje and Deputy Permanent Representative of Greece to the United Nations. She also served as Head of the European Union Rule of Law Mission (EULEX) in Kosovo. Ambassador Papadopoulou holds a Law Degree from the University of Athens and a Master’s Degree in International Relations/International Law from the University of Pennsylvania (Fulbright Scholar).
| Andreas Stavropoulos
Partner at Threshhold Venture Capital
Andreas invests in consumer and enterprise infrastructure, mobility, and technology-enabled services. He currently serves on the boards of Balena, CircleCI, Diamanti, Forward Networks, Mythic, NumberAI, and Tango, and supports Zymergen (NASDAQ:ZY). Past investments include Appstream (Symantec), Centerpost (West Corp.), Epocrates (NASDAQ: ATHN), Everdream (Dell), Lexent Bio (Foundation Medicine), Mobile 365 (Sybase), Meetup (WeWork), Silverpop (IBM), Vizu (Nielsen), and Yodle (Web.com). At their core, all of his investments have a platform element. Andreas believes that if entrepreneurs do things correctly and build a springboard, they can solve problems and quickly escalate the value they put into the ecosystem. He graduated Phi Beta Kappa and summa cum laude from Harvard University in computer science, along with an MA degree, and was first in his class at Harvard Business School where he was a Baker Scholar. He previously worked for McKinsey & Company and Cornerstone Research.
|Dr. Maria Chatzou Dunford
Founder & CEO at Lifebit
Chief Executive Officer. PhD in Biomedicine, MSc in Bioinformatics and BSc in Computer Science and Biomedical Informatics. Dr. Maria Chatzou Dunford has over 15 years of experience in bioinformatics, biomedicine and developing the tools and platforms necessary to bring large-scale precision medicine projects to life globally. As a biomedical researcher, Maria designed tools and methods that have revolutionised the analysis of large-scale biomedical data. Maria is a proactive and goal-oriented leader and an established industry expert in science-based solutions that propel genomics and personalised medicine forward, including HPC, Big Data, Cloud, and AI. A passionate entrepreneur, Dr. Chatzou Dunford has founded two companies: Innovation Forum Barcelona and Lifebit. Maria is a visionary in the field of bioinformatics and precision medicine, contributing to numerous consortia, high impact publications and international speaking engagements.
Founder & CEO at Dyania Health
Eirini Schlosser is a serial entrepreneur with experience building and leading data science and machine learning applications. After executing on > $60 Billion deal value in technology, healthcare, and consumer transactions as a member of Morgan Stanley’s Mergers & Acquisitions Execution Team, Eirini successfully transitioned from finance to technology where she spent the last decade developing designing technologies specifically in the machine learning space with applications in life sciences before founding Dyania Health in 2019. She holds professional certifications in machine learning from MIT and a Masters from London Business School.
|Dr. Maya Thanou
Co-Founder at Apeikon Therapeutics
Maya Thanou is a Reader in the Institute of Pharmaceutical Science, King’s College London. She finished her PhD in LACDR (Leiden/Amsterdam Centre for Drug Research) and after a short period in Kytogenics Pharmaceuticals, she moved as Lecturer in Cardiff University. She was awarded the Dorothy Hodgkin Royal Society Research Fellowship and she continued research at Imperial College London, at the Department of Chemistry. In her research she is engineering image guided nanoparticles, as novel drug delivery devices. She has published a book with the title Theranostics, Image guided drug delivery, about 90 academic articles and she is the inventor of several patents. In 2017 she co-founded the AJMmed-i-caps that focuses in developing products for colorectal cancer detection and in 2020 she co-founded Apeikon that develops theranostics and triggered targeted treatments for solid tumours. She is an academic innovator and entrepreneur.
Founder & CEO at Doctor Anytime
Eleftheria’s passion was always to stand by people’s side, to understand their needs, be in their shoes, support them and make them feel better and happier. She did that early on when just for fun she was helping her grandfather with sales in his little toy’s store in Crete, when parents were consulting her on what would be the most suitable toy for their kids. She followed marketing studies, and worked more than 10 years in big multinational fmcg companies like Loreal and PG. But deep within she wanted to leave her own mark in the society she lives in and disrupt one of the most difficult industries, the one of healthcare. In 2012 she made her dream come true and started doctoranytime, and ever since she daily enjoys smaller or bigger wins for patients and doctors making their lives easier, giving transparency to the whole process and making people feel they are in good hands. She keeps spreading the idea across continents and countries, currently operating in Greece, Cyprus, Belgium, Mexico, Brazil, Ecuador, and Colombia.
Endurance Partner in Residence at General Catalyst
Most recently, Margo served as the President and CEO of Ancestry where she brought together content, science and technology to transform Ancestry into the undisputed global leader in family history and consumer genomics. Margo also spent nine years at Google as the President of Americas and Vice President of Global Operations, leading the hyperscaling of commercial operations and advertising sales across all digital solutions including search, mobile, video, shopping, commerce, and platforms. She has served as the CEO of Mattel, the COO of Groupon, EVP of US Card Services and CMO of Discover Financial Services, and as a partner at McKinsey in London and Chicago. Margo is a champion of organizations that inspire women and girls to pursue education and careers in STEM and advancing the next generation of women leaders. She has received multiple awards for her business and community leadership including the Forbes “Excellence Award in Innovation,” Chicago Innovation’s “Visionary Award”, the Eastman Medal from the University of Rochester, Executive of the Year in Utah, and was named to Crain’s “Most Powerful Women in Business” and Fortune’s “50 Most Powerful Women in Business” lists. Margo serves on the Board of Directors of McDonald’s Corporation, AppLovin, Workboard, Handshake, Neeva, Catalyst and the Committee of 200. She earned a BA in Economics and an MBA from Harvard.
The Hellenic Innovation Network (HIN) has a mission to accelerate technological innovation and entrepreneurship in Greece to world-class level by 2030, thereby fueling the economy and job creation. As an outgrowth of MIT Enterprise Forum Greece, HIN is a US-based non-profit organization created with the support of the Consulate General of Greece in Boston to facilitate access to resources, partners, and best practices by building bridges between the diaspora in global tech hubs and the Greek tech community. Driven by an advisory group of global innovators, HIN disseminates startup news, broadcasts educational webcasts, organizes monthly CEO group meetings, and hosts in-person pitching and networking events.
Our online platform allows for virtual connections of our members in between events, so please register at hellenic.org to become part of our community and to learn more about Greek startups in the news.
During our live webcast, please send in questions with your name, and the speakers will address them at the end.
If you missed our prior webcasts, you can catch up here
(Wednesday) 12:00 pm - 1:00 pm